Kangstem Biotech강스템바이오텍
217730 · KOSDAQ · ₩217730 · 강스템바이오텍
₩1,872▼ ₩27 (1.42%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (퓨어스템-오에이 키트 주(FURESTEMOA Kit Inj.)(OSCA) 제1/2a상 임상시험 결과보고서(CSR) 수령)Oct 26, 2026Open on DART
Predicted impact: Medium
Phase 1/2a clinical study report received for osteoarthritis drug; early-stage result, outcome details not given, no prior items.
- Investor relations (IR) event기업설명회(IR)개최Sep 30, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 28, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (퓨어스템-오에이 키트 주(FURESTEM-OA Kit Inj.)(OSCA) 제2a상 임상시험 Topline data 수령)Jul 28, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (기술도입 계약 체결)Jul 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 2, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 3, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- [Amended] Change of 30% or More in Sales or Profit Structure (15% or More for Large Companies)[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Jan 23, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 13, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (퓨어스템-에이디주(FURESTEM-AD Inj.)의 반복투여 제1/2a 임상시험계획 변경승인)Nov 11, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 1, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 26, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 26, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Aug 25, 2025Open on DART
- [Amended] Securities Issuance Performance Report[기재정정]증권발행실적보고서Aug 25, 2025Open on DART
- Securities Issuance Results Report증권발행실적보고서Aug 25, 2025Open on DART
- Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Aug 19, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Aug 12, 2025Open on DART
- Amended: Prospectus[기재정정]투자설명서Aug 12, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Kangstem Biotech / 강스템바이오텍 / 217730 / KRX:217730
Source: KRX statistical information